AU2002308614A1 - Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives - Google Patents

Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives

Info

Publication number
AU2002308614A1
AU2002308614A1 AU2002308614A AU2002308614A AU2002308614A1 AU 2002308614 A1 AU2002308614 A1 AU 2002308614A1 AU 2002308614 A AU2002308614 A AU 2002308614A AU 2002308614 A AU2002308614 A AU 2002308614A AU 2002308614 A1 AU2002308614 A1 AU 2002308614A1
Authority
AU
Australia
Prior art keywords
disturbances
alteration
administration
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002308614A
Other languages
English (en)
Inventor
Mario Baraldi
Daniela Braghiroli
Giuseppe Cannazza
Wolfgang Lindner
Carlo Parenti
Giulia Puia
Annalisa Tait
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rett Corp
Original Assignee
Rett Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rett Corp filed Critical Rett Corp
Publication of AU2002308614A1 publication Critical patent/AU2002308614A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002308614A 2001-05-08 2002-05-07 Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives Abandoned AU2002308614A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2001BO000271A ITBO20010271A1 (it) 2001-05-08 2001-05-08 Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl
ITBO2001A000271 2001-05-08
PCT/US2002/014262 WO2002089734A2 (en) 2001-05-08 2002-05-07 Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives

Publications (1)

Publication Number Publication Date
AU2002308614A1 true AU2002308614A1 (en) 2002-11-18

Family

ID=11439316

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002308614A Abandoned AU2002308614A1 (en) 2001-05-08 2002-05-07 Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives

Country Status (4)

Country Link
EP (1) EP1435926A4 (de)
AU (1) AU2002308614A1 (de)
IT (1) ITBO20010271A1 (de)
WO (1) WO2002089734A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070182A1 (es) 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
EP1976495A2 (de) * 2006-01-06 2008-10-08 Aarhus Universitet Auf den serotonin-transporter wirkende verbindungen
BR112015031249A2 (pt) 2013-06-13 2017-07-25 Veroscience Llc método de tratamento, método para tratar um distúrbio metabólico ou um elemento chave do mesmo, método para normalizar um ritmo diário de liberação de dopamina no sumn, método para estimular a liberação de dopamina de neurônios dopaminérgicos no sumn de um indivíduo e composição farmacêutica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722502B1 (fr) * 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
US6083947A (en) * 1996-01-29 2000-07-04 The Regents Of The University Of California Method for treating sexual dysfunctions
US5939451A (en) * 1996-06-28 1999-08-17 Hoffmann-La Roche Inc. Use of sulfonamides
GB9818916D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Use

Also Published As

Publication number Publication date
EP1435926A4 (de) 2005-11-23
EP1435926A2 (de) 2004-07-14
WO2002089734A2 (en) 2002-11-14
ITBO20010271A1 (it) 2002-11-08
WO2002089734A3 (en) 2003-03-06
ITBO20010271A0 (it) 2001-05-08

Similar Documents

Publication Publication Date Title
AU2003301957A1 (en) Administration of anti-inflammatory drugs into the central nervous system
HK1070358A1 (en) Process for the preparation of 7-substituted-3-qu inoline and 3-quinol-4-one carbonitriles.
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
WO2003049675A3 (en) Treating muscle wasting with selective androgen receptor modulators
AU2002365516A1 (en) Benzamide derivatives, processes for their preparation, and their pharmaceutical use
AU2002307430A1 (en) Method and system for photodisruption of tissue of the eye
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
WO2001010816A3 (de) Substituierte 2-Dialkylaminoalkylbiphenyl-derivate
AU6910600A (en) Methods for the treatment of mental disorders
AU5636300A (en) Use of creatine or creatine analogs for the prevention and treatment of transmissible spongiform encephalopathies
AU4136901A (en) Novel methods for the treatment and prevention of dizziness and pruritus
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
WO2005091987A3 (en) Method of treating down syndrome
WO2000064423A3 (fr) Utilisation du saredutant et de ses sels pharmaceutiquement acceptables dans le traitement ou la prevention des troubles de l'humeur d'adaptation et de l'anxiete-depression
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
AU1036600A (en) Method for the production of quercetin and isoquercetin derivatives
AU2002308614A1 (en) Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
WO2004034889A3 (en) Photodynamic therapy for ocular neovascularization
AU2003297764A1 (en) System and method for single security administration
WO2002080978A3 (en) Pharmaceutical compositions comprising ascomycin
AU2003244132A1 (en) Method of examining allergic disaese and drug for treating the same
AU2002333448A1 (en) Derivatives of C2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
WO2001007038A3 (en) Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy
AU2003202255A1 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase